Controversy swirls around the approval of Zohydro, a new narcotic pain reliever manufactured by Zogenix, Inc. Zohydro ER is an opioid containing hydrocodone in capsule form that is intended as an extended-release formula. Zohydro is also one of the only opioid pain relievers to contain only hydrocodone and no acetaminophen, which can cause liver damage. Zohydro isn’t the first opioid created to treat chronic pain, so why the fuss? For one thing, Zohydro packs a bigger punch than its counterparts, containing 50 milligrams of hydrocodone in one capsule as compared to 10 milligrams in one Vicodin pill. And unlike oxycotin which pills turn into a jelly-like substance when crushed, Zohydro is tamper-resistance and when snorted or injected it’ll end send an entire dose into the bloodstream simultaneously which can lead to overdose and death.
Did you know that every day in the United States, 100 people die from a drug overdose, and a large percentage of deaths are due to prescription drug overdoses, particularly prescription painkillers?
La Paloma an treatment center that offers an integrated treatment plan for persons with substance abuse and/or co-occurring mental health disorders has created an article about Zohydro which goes into great detail about Zohydro as well as the following information:
- Zohydro’ road toward FDA Approval including the actions by Deval Patrick (Governor of Massachusetts) and Peter Shumlin (Governor of Vermont) to help mitigate the addition it can possibly cause....